The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Research Report 2025
Synopsis
A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
The global T-Cell & NK-Cell Engaging Bispecific Antibodies market was valued at US$ 472 million in 2023 and is anticipated to reach US$ 5107.7 million by 2030, witnessing a CAGR of 41.0% during the forecast period 2024-2030.
Global key players of T-Cell & NK-Cell engaging bispecific antibodies include Amgen and Immunocore. These two manufactures hold the total market share in the world. The key players are mainly located in Europe and North America. In terms of product, T-Cell engagers is the largest segment, with a share over 93%. And in terms of application, the largest application is solid tumors, with a share over 71%.
This report aims to provide a comprehensive presentation of the global market for T-Cell & NK-Cell Engaging Bispecific Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell & NK-Cell Engaging Bispecific Antibodies.
Report Scope
The T-Cell & NK-Cell Engaging Bispecific Antibodies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global T-Cell & NK-Cell Engaging Bispecific Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Immunocore
Johnson & Johnson
Roche
Pfizer
AbbVie
MacroGenics
Regeneron
Segment by Type
T-Cell Engagers
NK-Cell Engagers
Segment by Application
Hematological Cancers
Solid Tumors
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of T-Cell & NK-Cell Engaging Bispecific Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
The global T-Cell & NK-Cell Engaging Bispecific Antibodies market was valued at US$ 472 million in 2023 and is anticipated to reach US$ 5107.7 million by 2030, witnessing a CAGR of 41.0% during the forecast period 2024-2030.
Global key players of T-Cell & NK-Cell engaging bispecific antibodies include Amgen and Immunocore. These two manufactures hold the total market share in the world. The key players are mainly located in Europe and North America. In terms of product, T-Cell engagers is the largest segment, with a share over 93%. And in terms of application, the largest application is solid tumors, with a share over 71%.
This report aims to provide a comprehensive presentation of the global market for T-Cell & NK-Cell Engaging Bispecific Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell & NK-Cell Engaging Bispecific Antibodies.
Report Scope
The T-Cell & NK-Cell Engaging Bispecific Antibodies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global T-Cell & NK-Cell Engaging Bispecific Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Immunocore
Johnson & Johnson
Roche
Pfizer
AbbVie
MacroGenics
Regeneron
Segment by Type
T-Cell Engagers
NK-Cell Engagers
Segment by Application
Hematological Cancers
Solid Tumors
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of T-Cell & NK-Cell Engaging Bispecific Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview
1.1 Product Overview and Scope of T-Cell & NK-Cell Engaging Bispecific Antibodies
1.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Type
1.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value Comparison by Type (2024-2030)
1.2.2 T-Cell Engagers
1.2.3 NK-Cell Engagers
1.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Application
1.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value by Application: (2024-2030)
1.3.2 Hematological Cancers
1.3.3 Solid Tumors
1.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Estimates and Forecasts
1.4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue 2019-2030
1.4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales 2019-2030
1.4.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Competition by Manufacturers
2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Manufacturers (2019-2024)
2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Manufacturers (2019-2024)
2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price by Manufacturers (2019-2024)
2.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Product Type & Application
2.7 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Competitive Situation and Trends
2.7.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest T-Cell & NK-Cell Engaging Bispecific Antibodies Players Market Share by Revenue
2.7.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 T-Cell & NK-Cell Engaging Bispecific Antibodies Retrospective Market Scenario by Region
3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region: 2019-2030
3.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region: 2019-2024
3.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region: 2025-2030
3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region: 2019-2030
3.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region: 2019-2024
3.3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region: 2025-2030
3.4 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country
3.4.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2019-2030)
3.4.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country
3.5.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2019-2030)
3.5.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country
3.6.1 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2019-2030)
3.6.3 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country
3.7.1 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2019-2030)
3.7.3 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2019-2030)
3.8.3 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2019-2030)
4.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2019-2024)
4.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2025-2030)
4.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2019-2030)
4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2019-2030)
4.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2019-2024)
4.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2025-2030)
4.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2019-2030)
4.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2019-2030)
5 Segment by Application
5.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2019-2030)
5.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2019-2024)
5.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2025-2030)
5.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2019-2030)
5.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2019-2030)
5.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2019-2024)
5.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2025-2030)
5.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2019-2030)
5.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Immunocore
6.2.1 Immunocore Corporation Information
6.2.2 Immunocore Description and Business Overview
6.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.2.5 Immunocore Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Corporation Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
6.7 MacroGenics
6.6.1 MacroGenics Corporation Information
6.6.2 MacroGenics Description and Business Overview
6.6.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.7.5 MacroGenics Recent Developments/Updates
6.8 Regeneron
6.8.1 Regeneron Corporation Information
6.8.2 Regeneron Description and Business Overview
6.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.8.5 Regeneron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Chain Analysis
7.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Production Mode & Process
7.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Marketing
7.4.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Channels
7.4.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors
7.5 T-Cell & NK-Cell Engaging Bispecific Antibodies Customers
8 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Dynamics
8.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Trends
8.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers
8.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges
8.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
